1. Home
  2. XNET vs NNNN Comparison

XNET vs NNNN Comparison

Compare XNET & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNET
  • NNNN
  • Stock Information
  • Founded
  • XNET 2003
  • NNNN 2021
  • Country
  • XNET China
  • NNNN Germany
  • Employees
  • XNET N/A
  • NNNN N/A
  • Industry
  • XNET Computer Software: Prepackaged Software
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • XNET Technology
  • NNNN Health Care
  • Exchange
  • XNET Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • XNET 373.0M
  • NNNN 369.6M
  • IPO Year
  • XNET 2014
  • NNNN 2025
  • Fundamental
  • Price
  • XNET $4.73
  • NNNN $49.26
  • Analyst Decision
  • XNET
  • NNNN
  • Analyst Count
  • XNET 0
  • NNNN 0
  • Target Price
  • XNET N/A
  • NNNN N/A
  • AVG Volume (30 Days)
  • XNET 667.2K
  • NNNN 220.1K
  • Earning Date
  • XNET 08-12-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • XNET N/A
  • NNNN N/A
  • EPS Growth
  • XNET N/A
  • NNNN N/A
  • EPS
  • XNET N/A
  • NNNN 0.06
  • Revenue
  • XNET $331,614,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • XNET N/A
  • NNNN N/A
  • Revenue Next Year
  • XNET N/A
  • NNNN N/A
  • P/E Ratio
  • XNET N/A
  • NNNN $908.77
  • Revenue Growth
  • XNET N/A
  • NNNN 21.95
  • 52 Week Low
  • XNET $1.46
  • NNNN $5.18
  • 52 Week High
  • XNET $7.19
  • NNNN $53.11
  • Technical
  • Relative Strength Index (RSI)
  • XNET 48.14
  • NNNN N/A
  • Support Level
  • XNET $4.41
  • NNNN N/A
  • Resistance Level
  • XNET $4.91
  • NNNN N/A
  • Average True Range (ATR)
  • XNET 0.24
  • NNNN 0.00
  • MACD
  • XNET 0.04
  • NNNN 0.00
  • Stochastic Oscillator
  • XNET 70.22
  • NNNN 0.00

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: